Angiopoietin-like 4 serum levels on admission for acute myocardial infarction are associated with no-reflow.

MLA

Bouleti, Claire, et al. “Angiopoietin-like 4 Serum Levels on Admission for Acute Myocardial Infarction Are Associated with No-Reflow.” International Journal of Cardiology, vol. 187, 2015, pp. 511–16. EBSCOhost, https://doi.org/10.1016/j.ijcard.2015.03.263.

APA

Bouleti, C., Mathivet, T., Serfaty, J.-M., Vignolles, N., Berland, E., Monnot, C., Cluzel, P., Steg, P. G., Montalescot, G., & Germain, S. (2015). Angiopoietin-like 4 serum levels on admission for acute myocardial infarction are associated with no-reflow. International Journal of Cardiology, 187, 511–516. https://doi.org/10.1016/j.ijcard.2015.03.263

Chicago

Bouleti, Claire, Thomas Mathivet, Jean-Michel Serfaty, Nicolas Vignolles, Elodie Berland, Catherine Monnot, Philippe Cluzel, Philippe Gabriel Steg, Gilles Montalescot, and Stéphane Germain. 2015. “Angiopoietin-like 4 Serum Levels on Admission for Acute Myocardial Infarction Are Associated with No-Reflow.” International Journal of Cardiology 187: 511–16. doi:10.1016/j.ijcard.2015.03.263.